HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xianglai Xu Selected Research

Xianglai Xu Research Topics

Disease

11Renal Cell Carcinoma (Grawitz Tumor)
12/2024 - 09/2021
11Neoplasms (Cancer)
04/2024 - 12/2012
8Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 06/2013
3Prostatic Neoplasms (Prostate Cancer)
11/2017 - 07/2013
3Carcinogenesis
11/2013 - 08/2013
2Neoplasm Metastasis (Metastasis)
11/2013 - 07/2013
1Hyperplasia
11/2017
1Genetic Predisposition to Disease (Genetic Predisposition)
12/2012

Drug/Important Bio-Agent (IBA)

12Biomarkers (Surrogate Marker)IBA
04/2024 - 11/2013
9Tyrosine Kinase InhibitorsIBA
12/2024 - 01/2023
8Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2024 - 01/2023
8MicroRNAs (MicroRNA)IBA
11/2017 - 07/2013
2Cyclin D1IBA
11/2017 - 01/2015
2ApigeninIBA
02/2015 - 06/2013
1Galectin 1 (LGALS1)IBA
04/2024
1Phosphotransferases (Kinase)IBA
04/2024
1Annexin A2 (Annexin II)IBA
03/2024
1Immune Checkpoint InhibitorsIBA
01/2024
1Oxidoreductases (Dehydrogenase)IBA
01/2023
1Proline (L-Proline)FDA Link
01/2023
1Heme Oxygenase-1IBA
01/2023
1delta-1-pyrroline-5-carboxylateIBA
01/2023
1Cyclin-Dependent Kinase 6IBA
09/2014
1Proteins (Proteins, Gene)FDA Link
11/2013
1LuciferasesIBA
11/2013
1Messenger RNA (mRNA)IBA
11/2013
1Plasminogen Activators (Plasminogen Activator)IBA
12/2012
1PlasminogenIBA
12/2012
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
12/2012
1Plasminogen Activator Inhibitor 1IBA
12/2012

Therapy/Procedure

10Immunotherapy
12/2024 - 01/2023
8Therapeutics
12/2024 - 08/2013
1Nephrectomy
01/2023